Clinical Trial Update: Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

View source ↗

Summary

This clinical trial update explores whether tumor grade adds prognostic information beyond the 21-gene Recurrence Score in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Breast Cancer, Tumor Grade | Status: NOT_YET_RECRUITING